HIGHLIGHTS
SUMMARY
The prescription rate during the period 2012 to 2015 differs considerably from country to country: it is around 5% in the United_States and Iceland, but 0.5% in the United Kingdom. If the authors leave out children under 3, for whom the prescription of MPH remains exceptional, and if the authors take into account the fact that the population of 3-17-year-olds represents about one fifth of the French population, the authors can deduce from this study a prevalence of about 0.25% for 3-17-year-olds in 2011. (accessed June . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.